[{"id":"idea-tr1-ctdna-guided-stop-in-metastatic-disease","kind":"idea","name":"Use tumour DNA in blood to decide when to pause treatment in metastatic cancer","route":"/ideas/idea-tr1-ctdna-guided-stop-in-metastatic-disease/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/ideas-waves/wave-trials-1.ts","type":"changed","fields":[{"field":"test","before":"\"A phase 2/3 trial in a ctDNA-shedding cancer (colorectal or lung) randomising sustained-clearance patients to holiday vs continuation, with pre-specified non-inferiority on OS at two years.\"","after":"\"Run a phase 2/3 trial in a ctDNA-shedding cancer (colorectal or lung) randomising sustained-clearance patients to holiday vs continuation, with pre-specified non-inferiority on OS at two years.\""}]},{"id":"idea-tr1-ctdna-guided-stop-in-metastatic-disease","kind":"idea","name":"Use tumour DNA in blood to decide when to pause treatment in metastatic cancer","route":"/ideas/idea-tr1-ctdna-guided-stop-in-metastatic-disease/","commit":"c9201d8b2f","date":"2026-09-08","author":"Jude Gomila","message":"Ideas wave: clinical trials, part 1","file":"src/data/ideas-waves/wave-trials-1.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"maturity"},{"field":"actor"},{"field":"cost"},{"field":"horizonYears"},{"field":"bottlenecks"},{"field":"tldr"},{"field":"summary"},{"field":"hypothesis"},{"field":"rationale"},{"field":"test"},{"field":"technologies"},{"field":"terms"},{"field":"trials"},{"field":"cancers"},{"field":"companies"}]}]